Failure to ensure that everyone has access to prevention options to protect oneself from HIV acquisition, has resulted in at ...

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...

Since 1985, the event has shed a light on a virus that affects over 1.2 million people in the U.S. and nearly 58,000 in L.A.

As the nation's AIDS walk marks its 40th year in Los Angeles, organizers say medical advances have taken lowered visibility ...

There is currently no cure for HIV, but there are effective drug treatments available on the NHS. AIDS, stands for acquired ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

Extreme weather events are associated with disruptions to HIV services. Owing to the design of the included studies, we could ...

Note: ViiV’s announcement can be read on their site at ...

Mandelman’s ordinance would also repeal regulations passed at the height of the AIDS crisis in the 1980s that required ...

Self-care technologies are key for improving health and well-being — and for reaching universal health coverage by 2030.

The drugmaker Gilead Sciences on Wednesday announced a plan to allow six generic pharmaceutical companies in Asia and North ...

Why Gilead cut a deal with 6 generics companies around a yet-to-be-approved, twice-a-year HIV PrEP drug: "It really is all ...